tiprankstipranks
Trending News
More News >
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market

Eton Pharmaceuticals (ETON) Financial Statements

Compare
520 Followers

Eton Pharmaceuticals Financial Overview

Eton Pharmaceuticals's market cap is currently $414.60M. The company's EPS TTM is $0.04; its P/E ratio is -62.10; Eton Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 39.01M$ 31.64M$ 21.25M$ 21.83M$ 39.00K
Gross Profit$ 23.41M$ 21.06M$ 14.32M$ 19.21M$ -247.00K
Operating Income$ -2.60M$ -1.19M$ -8.26M$ -1.50M$ -27.11M
EBITDA$ -1.45M$ -291.00K$ -6.49M$ -1.03M$ -26.46M
Net Income$ -3.82M$ -936.00K$ -9.02M$ -1.96M$ -27.97M
Balance Sheet
Cash & Short-Term Investments$ 14.94M$ 21.39M$ 16.30M$ 14.41M$ 21.30M
Total Assets$ 76.12M$ 31.74M$ 25.03M$ 27.46M$ 26.32M
Total Debt$ 29.92M$ 5.40M$ 6.52M$ 6.70M$ 7.14M
Net Debt$ 14.98M$ -15.99M$ -9.78M$ -7.71M$ -14.15M
Total Liabilities$ 51.70M$ 16.26M$ 11.95M$ 9.84M$ 10.66M
Stockholders' Equity$ 24.43M$ 15.48M$ 13.08M$ 17.63M$ 15.66M
Cash Flow
Free Cash Flow$ 943.00K$ 6.04M$ 2.03M$ -7.98M$ -22.40M
Operating Cash Flow$ 969.00K$ 6.82M$ 4.82M$ -4.72M$ -22.35M
Investing Cash Flow$ -40.01M$ -775.00K$ -2.79M$ -2.56M$ -50.00K
Financing Cash Flow$ 32.59M$ -957.00K$ -134.00K$ 391.00K$ 31.63M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Eton Pharmaceuticals Debt to Assets

Eton Pharmaceuticals Cash Flow

Eton Pharmaceuticals Forecast EPS vs Actual EPS